Prophylactic Use of Entecavir for Lymphoma Patients With Past Hepatitis B Virus Infection: A Randomized Controlled Trial

Authors:

Abstract
No abstract available
Funding Information
  • CSCO (Y-Q2017-035)
  • Scientific Research Fund for the Treatment of Chronic Anemia in China (LIM-SS-16001)
  • Capital Funds for Health Improvement and Research (2018-1-2151)
  • Beijing Municipal Administration of Hospitals (XMLX201502)

This publication has 26 references indexed in Scilit: